Information for healthcare providers : Tecovirimat (TPOXX) for treatment of mpox

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Information for healthcare providers : Tecovirimat (TPOXX) for treatment of mpox

[PDF-1.43 MB]

English

Details Supporting Files You May Also Like

Details:

Corporate Authors:

National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology.
Description:

Updated June 7, 2023
Content Notes:

Summary of Recent Changes -- Oral Tecovirimat Access through the STOMP Trial -- Tecovirimat Expanded Access IND Information -- Tecovirimat (TPOXX) IND Online Registry -- Tecovirimat EA-IND Protocol -- Institutional Review Board (IRB) Approval of Tecovirimat IND Protocol.
Subjects:

[+]

Antiviral Agents Drugs, Investigational Mpox (monkeypox) Poxviridae Infections/drug Therapy Smallpox/drug Therapy
Document Type:

Webpage
Name as Subject:

Tecovirimat ; Tecovirimat

Tecovirimat ; Tecovirimat Less -
Place as Subject:

United States
Collection(s):

Stephen B. Thacker CDC Library collection
Main Document Checksum:

[+]

urn:sha256:965091fb6970ebd23f9d92b6cc7130ff979969a4115e9e5be7f090b7736f5366
Download URL:

https://stacks.cdc.gov/view/cdc/129512/cdc_129512_DS1.pdf
File Type:

obtaining-tecovirimat.html

htm

More +